Header cover image

French (CAC) Pharma Industry Analysis

UpdatedJan 20, 2022
DataAggregated Company Financials
Companies9
  • 7D1.8%
  • 3M8.0%
  • 1Y12.9%
  • YTD2.5%

Over the last 7 days, the Pharma industry has risen 1.8%, driven by gains from Sanofi of 2.0%. This takes the industry's 12 month performance to a gain of 13%.

Industry Valuation and Performance

Has the French Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Fri, 21 Jan 2022€127.8b€43.2b€7.0b20.3x
Sun, 19 Dec 2021€121.9b€43.2b€7.0b21.6x
Tue, 16 Nov 2021€127.0b€43.2b€7.0b21.7x
Thu, 14 Oct 2021€117.7b€42.3b€6.6b18.8x
Sat, 11 Sep 2021€114.9b€42.2b€6.6b21.7x
Mon, 09 Aug 2021€122.2b€42.2b€6.6b20.5x
Sun, 02 May 2021€120.3b€41.6b€12.9b16.6x
Wed, 03 Feb 2021€106.8b€41.9b€13.0b13.2x
Sat, 07 Nov 2020€107.1b€42.2b€11.6b20.3x
Fri, 31 Jul 2020€121.1b€42.3b€11.2b18.1x
Mon, 04 May 2020€120.1b€42.8b€3.5b23.8x
Thu, 06 Feb 2020€117.8b€42.2b€3.0b30.1x
Sun, 10 Nov 2019€114.6b€41.4b€3.4b32.6x
Sat, 03 Aug 2019€106.0b€41.1b€4.1b21.2x
Tue, 07 May 2019€108.3b€40.6b€4.9b21.8x
Fri, 08 Feb 2019€105.2b€39.9b€4.8b21.6x
PE Ratio

21.6x

Total Market Cap: €105.2bTotal Earnings: €4.8bTotal Revenue: €39.9b0%0%0%3 Year10 Year
202020212022

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 21.9x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 13% per year over the last three years, and revenues for these companies have grown 2.7% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the French Pharma industry?

Pharma1.79%

Industry PE: Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 21.9x. This is likely because analysts are expecting annual earnings growth of 9.4%, which is higher than its past year's earnings decline of 6.6% per year.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 9.4% over the next 5 years. This is better than its past earnings decline of 6.6% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SAN Sanofi€92.924.5%
+€5.0b
14.1%PE18.9x
IPN Ipsen€83.401.5%
+€100.3m
16.2%PE10.9x
BOI Boiron€36.352.0%
+€12.3m
1.0%PE36x
ADVIC Advicenne€8.620.2%
+€197.7k
-27.3%PS23.5x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

VIRP

€379.00

Virbac

7D

-3.1%

1Y

72.3%

AB

€10.90

AB Science

7D

-10.1%

1Y

-34.3%

SAN

€92.92

Sanofi

7D

4.5%

1Y

14.1%

IPN

€83.40

Ipsen

7D

1.5%

1Y

16.2%

MEDCL

€8.50

MedinCell

7D

-7.0%

1Y

-45.7%

BOI

€36.35

Boiron

7D

2.0%

1Y

1.0%